ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 45 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,721,000 | +30.8% | 1,784,913 | +0.7% | 1.90% | +25.8% |
| Q3 2021 | $18,906,000 | -18.3% | 1,771,844 | -31.1% | 1.51% | -29.1% |
| Q2 2021 | $23,143,000 | -15.1% | 2,571,450 | 0.0% | 2.13% | -2.4% |
| Q1 2021 | $27,257,000 | -15.9% | 2,571,450 | 0.0% | 2.19% | -12.4% |
| Q4 2020 | $32,400,000 | +43.3% | 2,571,450 | 0.0% | 2.50% | +23.0% |
| Q3 2020 | $22,603,000 | -9.5% | 2,571,450 | 0.0% | 2.03% | -7.5% |
| Q2 2020 | $24,969,000 | +237.1% | 2,571,450 | 0.0% | 2.19% | +161.1% |
| Q1 2020 | $7,406,000 | -25.0% | 2,571,450 | 0.0% | 0.84% | -49.3% |
| Q4 2019 | $9,874,000 | -3.0% | 2,571,450 | 0.0% | 1.66% | -48.0% |
| Q3 2019 | $10,183,000 | -5.9% | 2,571,450 | 0.0% | 3.18% | +14.8% |
| Q2 2019 | $10,826,000 | -38.6% | 2,571,450 | 0.0% | 2.77% | -34.7% |
| Q1 2019 | $17,640,000 | +118.0% | 2,571,450 | +16.9% | 4.25% | +103.4% |
| Q4 2018 | $8,092,000 | -41.9% | 2,199,011 | 0.0% | 2.09% | -18.1% |
| Q3 2018 | $13,920,000 | -16.4% | 2,199,011 | 0.0% | 2.55% | -26.1% |
| Q2 2018 | $16,647,000 | -5.4% | 2,199,011 | 0.0% | 3.45% | +18.1% |
| Q1 2018 | $17,592,000 | -28.6% | 2,199,011 | 0.0% | 2.92% | -26.9% |
| Q4 2017 | $24,629,000 | -3.4% | 2,199,011 | 0.0% | 3.99% | -56.1% |
| Q3 2017 | $25,509,000 | – | 2,199,011 | – | 9.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,056,420 | $22,006,000 | 19.85% |
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $48,300,000 | 17.51% |
| GREAT POINT PARTNERS LLC | 3,448,521 | $24,829,000 | 5.98% |
| Omega Fund Management, LLC | 2,029,580 | $14,613,000 | 5.35% |
| Paradigm Biocapital Advisors LP | 2,214,722 | $15,946,000 | 2.13% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $21,497,000 | 1.66% |
| COMMODORE CAPITAL LP | 1,325,000 | $9,540,000 | 1.53% |
| Octagon Capital Advisors LP | 1,225,000 | $8,820,000 | 1.52% |
| RA Capital Management | 4,356,632 | $31,368,000 | 0.67% |
| TCG Crossover Management, LLC | 254,569 | $1,833,000 | 0.55% |